Kips Bay Medical Inc (KIPS) financial statements (2022 and earlier)
Company profile
| Business Address |
3405 ANNAPOLIS LANE MINNEAPOLIS, MN 55447 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| SIC | 3841 - Surgical and Medical Instruments and Apparatus (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in thousands)
| 12/31/2014 | 12/31/2013 | 12/31/2012 | |||
|---|---|---|---|---|---|
| ASSETS | |||||
| Current Assets | |||||
| Cash, cash equivalents, and short-term investments, including: | 3,600 | 5,000 | 10,350 | ||
| Cash and cash equivalents | 3,138 | 2,316 | 9,403 | ||
| Short-term investments | 457 | 2,684 | 947 | ||
| Other undisclosed cash, cash equivalents, and short-term investments | 5 | ||||
| Receivables | 8 | 28 | 31 | ||
| Inventory, net of allowances, customer advances and progress billings | 673 | 793 | 915 | ||
| Inventory | 673 | 793 | 915 | ||
| Prepaid expense and other current assets | ✕ | ✕ | 103 | ||
| Other undisclosed current assets | 104 | 88 | |||
| Total current assets: | 4,385 | 5,909 | 11,399 | ||
| Noncurrent Assets | |||||
| Property, plant and equipment | 353 | 400 | 457 | ||
| Total noncurrent assets: | 353 | 400 | 457 | ||
| TOTAL ASSETS: | 4,738 | 6,309 | 11,856 | ||
| LIABILITIES AND EQUITY | |||||
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 469 | 455 | 788 | ||
| Accounts payable | 78 | 141 | 333 | ||
| Accrued liabilities | 355 | 314 | 455 | ||
| Employee-related liabilities | 36 | ||||
| Other undisclosed current liabilities | (36) | ||||
| Total current liabilities: | 433 | 455 | 788 | ||
| Noncurrent Liabilities | |||||
| Total liabilities: | 433 | 455 | 788 | ||
| Stockholders' equity | |||||
| Stockholders' equity attributable to parent | 4,305 | 5,854 | 11,068 | ||
| Common stock | 330 | 270 | 263 | ||
| Additional paid in capital | 45,492 | 41,494 | 40,655 | ||
| Accumulated deficit | (41,517) | (35,910) | (29,850) | ||
| Total stockholders' equity: | 4,305 | 5,854 | 11,068 | ||
| TOTAL LIABILITIES AND EQUITY: | 4,738 | 6,309 | 11,856 | ||
Income statement (P&L) ($ in thousands)
| 12/31/2014 | 12/31/2013 | 12/31/2012 | ||
|---|---|---|---|---|
| Revenues (Revenue, Net) | 84 | 130 | 226 | |
| Cost of revenue (Cost of Goods and Services Sold) | (44) | (63) | (98) | |
| Gross profit: | 40 | 67 | 128 | |
| Operating expenses | (5,653) | (6,143) | (5,650) | |
| Operating loss: | (5,613) | (6,076) | (5,522) | |
| Nonoperating expense (Investment Income, Nonoperating) | (14) | (58) | (64) | |
| Other undisclosed income from continuing operations before equity method investments, income taxes | 79 | |||
| Net loss attributable to parent: | (5,627) | (6,134) | (5,507) | |
| Other undisclosed net income available to common stockholders, basic | 20 | 74 | ||
| Net loss available to common stockholders, diluted: | (5,607) | (6,060) | (5,507) | |
Comprehensive Income ($ in thousands)
| 12/31/2014 | 12/31/2013 | 12/31/2012 | ||
|---|---|---|---|---|
| Net loss: | (5,627) | (6,134) | (5,507) | |
| Comprehensive loss: | (5,627) | (6,134) | (5,507) | |
| Other undisclosed comprehensive income, net of tax, attributable to parent | 20 | 74 | 3 | |
| Comprehensive loss, net of tax, attributable to parent: | (5,607) | (6,060) | (5,504) | |
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.